Filing Details

Accession Number:
0001683168-24-001322
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-03-05 16:05:35
Reporting Period:
2024-03-04
Accepted Time:
2024-03-05 16:05:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1402328 Sunshine Biopharma Inc SBFM Pharmaceutical Preparations (2834) 205566275
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1474684 N. Steve Slilaty 1177 Avenue Of The Americas, 5Th Floor
New York NY 10036
Chief Executive Officer Yes Yes Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Series B Preferred Stock Acquisiton 2024-03-04 100,000 $0.10 130,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct